GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vasamed Inc (OTCPK:VSMD) » Definitions » Cyclically Adjusted Revenue per Share

Vasamed (Vasamed) Cyclically Adjusted Revenue per Share : $0.00 (As of Sep. 2006)


View and export this data going back to 1996. Start your Free Trial

What is Vasamed Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vasamed's adjusted revenue per share for the three months ended in Sep. 2006 was $0.133. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2006.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-25), Vasamed's current stock price is $0.0001. Vasamed's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2006 was $0.00. Vasamed's Cyclically Adjusted PS Ratio of today is .


Vasamed Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Vasamed's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vasamed Cyclically Adjusted Revenue per Share Chart

Vasamed Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vasamed Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vasamed's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Vasamed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vasamed's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vasamed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vasamed's Cyclically Adjusted PS Ratio falls into.



Vasamed Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vasamed's adjusted Revenue per Share data for the three months ended in Sep. 2006 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2006 (Change)*Current CPI (Sep. 2006)
=0.133/85.6057*85.6057
=0.133

Current CPI (Sep. 2006) = 85.6057.

Vasamed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
199612 0.055 66.915 0.070
199703 0.071 67.506 0.090
199706 0.073 67.632 0.092
199709 0.072 68.012 0.091
199712 0.029 68.054 0.036
199803 0.138 68.434 0.173
199806 0.203 68.771 0.253
199809 0.203 69.025 0.252
199812 0.148 69.151 0.183
199903 0.041 69.615 0.050
199906 0.000 70.122 0.000
199909 0.000 70.839 0.000
199912 0.023 71.008 0.028
200003 0.000 72.231 0.000
200006 0.000 72.737 0.000
200009 0.000 73.286 0.000
200012 0.000 73.413 0.000
200103 0.000 74.341 0.000
200106 0.000 75.100 0.000
200109 0.000 75.227 0.000
200112 0.000 74.552 0.000
200203 0.130 75.438 0.148
200206 0.124 75.902 0.140
200209 0.006 76.366 0.007
200212 0.305 76.324 0.342
200303 0.279 77.716 0.307
200306 0.082 77.505 0.091
200309 0.176 78.138 0.193
200312 0.129 77.758 0.142
200403 0.058 79.066 0.063
200406 0.068 80.037 0.073
200409 0.078 80.121 0.083
200412 0.101 80.290 0.108
200503 0.075 81.555 0.079
200506 0.054 82.062 0.056
200509 0.091 83.876 0.093
200512 0.150 83.032 0.155
200603 0.120 84.298 0.122
200606 0.121 85.606 0.121
200609 0.133 85.606 0.133

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Vasamed  (OTCPK:VSMD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vasamed Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Vasamed's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vasamed (Vasamed) Business Description

Industry
Traded in Other Exchanges
N/A
Address
7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733
Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.

Vasamed (Vasamed) Headlines

No Headlines